Use of the oral beta blocker bisoprolol to reduce the rate of exacerbation in people with chronic obstructive pulmonary disease (COPD): a randomised controlled trial (BICS).
Trials
; 23(1): 307, 2022 Apr 14.
Article
de En
| MEDLINE
| ID: mdl-35422024
Texte intégral:
1
Collection:
01-internacional
Base de données:
MEDLINE
Sujet principal:
Broncho-pneumopathie chronique obstructive
/
Défaillance cardiaque
Type d'étude:
Clinical_trials
/
Diagnostic_studies
/
Observational_studies
/
Prognostic_studies
Limites:
Adult
/
Humans
Langue:
En
Journal:
Trials
Sujet du journal:
MEDICINA
/
TERAPEUTICA
Année:
2022
Type de document:
Article
Pays d'affiliation:
Royaume-Uni
Pays de publication:
Royaume-Uni